Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerold Schuler

Showing results (61-70 of 188) with videos related to

Pageof 19
Sort By:
Plos One|February 9, 2013
Just one position-independent lysine residue can direct MelanA into proteasomal degradation following N-terminal fusion of ubiquitinChristian Setz, Melanie Friedrich, Sabine Hahn, et al.
Anticancer Research|November 7, 2018
Risk Factors for Regional and Systemic Metastases in Patients with Sentinel Lymph Node-negative MelanomaMichael Erdmann, Dominic Sigler, Ugur Uslu, et al.
Current Protocols in Immunology|August 5, 2009
Isolation of dendritic cellsKayo Inaba, William J Swiggard, Ralph M Steinman, et al.
International Journal of Cancer|January 29, 2009
Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4+ T cells in melanoma patientsCornelia Erfurt, Esther Müller, Sonja Emmerling, et al.
Dermatology (Basel, Switzerland)|June 22, 2002
Segmental neurofibromatosisErwin S Schultz, Dieter Kaufmann, Sigrid Tinschert, et al.
Anticancer Research|May 29, 2017
Sarcoidosis Under Dendritic Cell Vaccination Immunotherapy in Long-term Responding Patients with Metastatic MelanomaUgur Uslu, Michael Erdmann, Stefan Schliep, et al.
International Journal of Molecular Sciences|January 19, 2018
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell TherapyJan Dörrie, Lek Babalija, Stefanie Hoyer, et al.
European Journal of Dermatology : EJD|December 3, 2014
Treatment of vitiligo using targeted UVB-Intense Pulsed Light (IPL)- phototherapy: evaluation of variables affecting therapeutic successAnke Hartmann, Anne Schmidt-Habel, Lisa Löhberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSFManfred B Lutz, Markus Schnare, Mauritius Menges, et al.
Cancers|August 21, 2019
Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP ComplianceManuel Wiesinger, Johannes März, Mirko Kummer, et al.
Pageof 19

Showing results (61-70 of 188) with videos related to

Sort By:
Pageof 19
Plos One|February 9, 2013
Just one position-independent lysine residue can direct MelanA into proteasomal degradation following N-terminal fusion of ubiquitinChristian Setz, Melanie Friedrich, Sabine Hahn, et al.
Anticancer Research|November 7, 2018
Risk Factors for Regional and Systemic Metastases in Patients with Sentinel Lymph Node-negative MelanomaMichael Erdmann, Dominic Sigler, Ugur Uslu, et al.
Current Protocols in Immunology|August 5, 2009
Isolation of dendritic cellsKayo Inaba, William J Swiggard, Ralph M Steinman, et al.
International Journal of Cancer|January 29, 2009
Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4+ T cells in melanoma patientsCornelia Erfurt, Esther Müller, Sonja Emmerling, et al.
Dermatology (Basel, Switzerland)|June 22, 2002
Segmental neurofibromatosisErwin S Schultz, Dieter Kaufmann, Sigrid Tinschert, et al.
Anticancer Research|May 29, 2017
Sarcoidosis Under Dendritic Cell Vaccination Immunotherapy in Long-term Responding Patients with Metastatic MelanomaUgur Uslu, Michael Erdmann, Stefan Schliep, et al.
International Journal of Molecular Sciences|January 19, 2018
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell TherapyJan Dörrie, Lek Babalija, Stefanie Hoyer, et al.
European Journal of Dermatology : EJD|December 3, 2014
Treatment of vitiligo using targeted UVB-Intense Pulsed Light (IPL)- phototherapy: evaluation of variables affecting therapeutic successAnke Hartmann, Anne Schmidt-Habel, Lisa Löhberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSFManfred B Lutz, Markus Schnare, Mauritius Menges, et al.
Cancers|August 21, 2019
Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP ComplianceManuel Wiesinger, Johannes März, Mirko Kummer, et al.
Pageof 19